Shareholdings
| Concept |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholdings | ||||||||||
| Reporting company | ||||||||||
| Details of specified investment shares held for purposes other than pure investment | ||||||||||
| Issue |
株式会社ほくやく・竹山ホールディングス
|
FibroGen,Inc.
|
Roivant Sciences Ltd.
|
Cytokinetics, Incorporated
|
オンコリスバイオファーマ株式会社
|
— | — | — | — | — |
| Number of shares |
xbrli:shares
|
4,968,367
xbrli:shares
|
xbrli:shares
|
xbrli:shares
|
727,200
xbrli:shares
|
402,721
xbrli:shares
|
727,200
xbrli:shares
|
4,968,367
xbrli:shares
|
2,040,816
xbrli:shares
|
599,800
xbrli:shares
|
| Carrying amount |
JPY
|
12,311,000,000
JPY
|
JPY
|
JPY
|
415,000,000
JPY
|
242,000,000
JPY
|
486,000,000
JPY
|
7,266,000,000
JPY
|
9,139,000,000
JPY
|
396,000,000
JPY
|
| Whether issuer of aforementioned shares holds reporting company's shares |
有
|
無
|
無
|
無
|
無
|
— | — | — | — | — |